IL147505A0 - Neurotrophic pyrrolidines and piperidines, and related compositions and methods - Google Patents

Neurotrophic pyrrolidines and piperidines, and related compositions and methods

Info

Publication number
IL147505A0
IL147505A0 IL14750500A IL14750500A IL147505A0 IL 147505 A0 IL147505 A0 IL 147505A0 IL 14750500 A IL14750500 A IL 14750500A IL 14750500 A IL14750500 A IL 14750500A IL 147505 A0 IL147505 A0 IL 147505A0
Authority
IL
Israel
Prior art keywords
pyrrolidines
piperidines
neurotrophic
methods
related compositions
Prior art date
Application number
IL14750500A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL147505A0 publication Critical patent/IL147505A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL14750500A 1999-07-09 2000-06-14 Neurotrophic pyrrolidines and piperidines, and related compositions and methods IL147505A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14300699P 1999-07-09 1999-07-09
PCT/US2000/016221 WO2001004116A2 (en) 1999-07-09 2000-06-14 Neurotrophic pyrrolidines and piperidines, and related compositions containing them

Publications (1)

Publication Number Publication Date
IL147505A0 true IL147505A0 (en) 2002-08-14

Family

ID=22502172

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14750500A IL147505A0 (en) 1999-07-09 2000-06-14 Neurotrophic pyrrolidines and piperidines, and related compositions and methods
IL147505A IL147505A (en) 1999-07-09 2002-01-07 Pyrolidines and neurotrophic piperidines and their use in the preparation of drugs containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147505A IL147505A (en) 1999-07-09 2002-01-07 Pyrolidines and neurotrophic piperidines and their use in the preparation of drugs containing them

Country Status (17)

Country Link
US (1) US6809107B1 (ru)
EP (1) EP1202990A2 (ru)
JP (1) JP2003504367A (ru)
KR (1) KR20020027486A (ru)
CN (1) CN1382140A (ru)
AR (1) AR034541A1 (ru)
AU (1) AU781235B2 (ru)
BR (1) BR0012327A (ru)
CA (1) CA2379149A1 (ru)
CZ (1) CZ200265A3 (ru)
HU (1) HUP0202249A3 (ru)
IL (2) IL147505A0 (ru)
MX (1) MXPA02000330A (ru)
PL (1) PL352432A1 (ru)
RU (1) RU2241709C2 (ru)
TW (1) TW589311B (ru)
WO (1) WO2001004116A2 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835254B1 (fr) * 2002-01-25 2006-04-07 Sod Conseils Rech Applic Derives de thiazoles dans le traitement de maladies neurologiques
DE10240818A1 (de) * 2002-08-30 2004-05-13 Grünenthal GmbH Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate
SI1551835T1 (sl) * 2002-09-30 2007-06-30 Neurosearch As Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba
US7189746B2 (en) * 2002-11-08 2007-03-13 Gliamed, Inc. Methods for promoting wound healing
US20040266811A1 (en) * 2002-11-08 2004-12-30 Weinstein David E. Methods for inducing regeneration, remyelination, and hypermyelination of nervous tissue
WO2006116808A1 (en) * 2005-04-29 2006-11-09 Metabolic Pharmaceuticals Limited Treating peripheral neuropathies
US20080015236A1 (en) * 2006-02-08 2008-01-17 Weinstein David E Method for promoting myocardial regeneration and uses thereof
US7795216B2 (en) * 2006-03-24 2010-09-14 Glia Med, Inc. Methods for promoting composite tissue regeneration and uses thereof
GB0701426D0 (en) * 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use
TWI534142B (zh) * 2011-03-15 2016-05-21 大正製藥股份有限公司 Azole derivatives
SG11201601682RA (en) * 2013-09-06 2016-04-28 Aurigene Discovery Tech Ltd 1,2,4-oxadiazole derivatives as immunomodulators
KR102526625B1 (ko) * 2014-12-17 2023-04-27 킹즈 컬리지 런던 레티노산 수용체 베타 (RARβ) 작동제로서 바이사이클로헤테로아릴-헤테로아릴-벤조산 화합물
JP6951336B2 (ja) * 2015-12-04 2021-10-20 ザ ペン ステイト リサーチ ファウンデーション 小分子カクテルによるヒトグリア細胞からニューロンへの化学的リプログラミング
CN114591295B (zh) * 2022-03-04 2023-11-07 贵州大学 含吡啶盐的n-(吲哚酰基)-n’-(取代的)的丙基酰肼类衍生物、其制备方法及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950649A (en) 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
DE3721534A1 (de) * 1986-08-02 1988-02-11 Basf Ag Thiadiazolgruppen enthaltende polymere und deren verwendung in der elektroindustrie
HU217621B (hu) 1991-05-09 2000-03-28 Vertex Pharmaceuticals Inc. Eljárás új glioxaloil-pipekolinsav-észterek, származékaik és az ezeket tartalmazó gyógyszerkészítmények előállítására
US5461146A (en) 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5621101A (en) 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5756494A (en) 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
NZ314207A (en) 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
WO1996006097A1 (en) 1994-08-18 1996-02-29 Ariad Gene Therapeutics, Inc. New multimerizing agents
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
JP4936345B2 (ja) 1996-02-28 2012-05-23 アリアド・ファーマシューティカルズ・インコーポレイテッド イムノフィリン由来ドメインとのキメラタンパク質用の多量体化剤としてのラパマイシンの合成誘導体
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
PA8442401A1 (es) 1996-12-09 2000-05-24 Guilford Pharm Inc Inhibidores polipropilos de ciclofilina
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5935989A (en) * 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
AU742040C (en) * 1997-09-24 2003-10-02 Amgen, Inc. Method for preventing and treating hearing loss using sensorineurotrophic compounds
GB9804426D0 (en) 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
JP4722288B2 (ja) * 1998-06-03 2011-07-13 ジーピーアイ ニル ホールディングス インコーポレイテッド 神経学上の傷害および毛髪損失を治療するために使用されるａｚａ−複素環式化合物
JP2002516903A (ja) * 1998-06-03 2002-06-11 ジーピーアイ ニル ホールディングス インコーポレイテッド Ｎ−複素環式カルボキシル酸およびカルボキシル酸等配電子体の尿素およびカルバメート
EA200001144A1 (ru) 1998-06-03 2001-10-22 Джи-Пи-Ай Эн-Ай-Эл Холдингз, Инк. Аза-гетероциклические соединения, применяемые для лечения неврологических расстройств и выпадения волос
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6284779B1 (en) 1999-02-03 2001-09-04 Schering Aktiiengesellschaft Heteroaromatic compounds

Also Published As

Publication number Publication date
HUP0202249A3 (en) 2003-01-28
CN1382140A (zh) 2002-11-27
PL352432A1 (en) 2003-08-25
KR20020027486A (ko) 2002-04-13
BR0012327A (pt) 2002-07-02
AU5485500A (en) 2001-01-30
CZ200265A3 (cs) 2002-07-17
WO2001004116A3 (en) 2001-08-23
AU781235B2 (en) 2005-05-12
TW589311B (en) 2004-06-01
US6809107B1 (en) 2004-10-26
IL147505A (en) 2006-07-05
EP1202990A2 (en) 2002-05-08
RU2241709C2 (ru) 2004-12-10
JP2003504367A (ja) 2003-02-04
HUP0202249A2 (hu) 2002-12-28
AR034541A1 (es) 2004-03-03
WO2001004116A2 (en) 2001-01-18
MXPA02000330A (es) 2004-05-21
CA2379149A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
IL150550A0 (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
EP1451173A4 (en) PIPERIDINE
HK1065036A1 (en) pyrrolidine and piperidine derivatives as nk1 antagonists
PL361463A1 (en) Cyanopyrrolidine derivatives
GR3036208T3 (en) Paroxetine methansulfonate
HUP0200811A2 (en) Solid composition, its producing and using
IL147505A0 (en) Neurotrophic pyrrolidines and piperidines, and related compositions and methods
IL143600A (en) Il-174 polynucleotides, polypeptides and related compositions and methods
IL154422A0 (en) Paroxetine compositions and processes for making the same
GB0016698D0 (en) Tie
HU9904086D0 (en) New 4-substituted piperidines
ZA991038B (en) Pyrrolidine and piperidine derivatives.
AU1018801A (en) Use of 3,4-substituted piperidines
PL343095A1 (en) Paroxetine compositions
AU5606400A (en) Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
AU4566399A (en) Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
AU4732001A (en) Thiepino (3,2-b) dihydropyridines and related compositions and methods
AU5483500A (en) Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
EP1311709A4 (en) METHODS AND COMPOSITIONS FOR DIRECTED MOLECULAR EVOLUTION USING MODIFICATION OF THE END OF DNA
GB9904614D0 (en) Piperidines
HK1045506B (zh) 氧硫庚英並[6，5-b]二氫吡啶和相關組合物及其製備方法
GB9905907D0 (en) Sterilant composition
PL337298A1 (en) Paraffin-wax compositions
GB9904157D0 (en) Mitre block
CA89270S (en) Tie

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed